Current Edition

Considerations for Oncology Clinical Trials in Asia

Asia is an important destination for oncology clinical trials, accounting for half the global burden of cancer, with disproportionate levels of liver, stomach, and oesophageal cancer. David Fuller, Senior Vice President of Oncology at INC Research, summarises key considerations for successful oncology trials in Asia, including healthcare systems, standard of care (SOC), regional expertise and the Asian regulatory environment.….pdf